Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03617328
Title Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma (Mel-65)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Craig L Slingluff, Jr
Indications

melanoma

Therapies

6MHP vaccine + Montanide ISA 51 + Poly ICLC + Varlilumab

6MHP vaccine + Montanide ISA 51 + Poly ICLC

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Virginia Recruiting Charlottesville Virginia 22908 United States Details
Virginia Commonwealth University Recruiting Richmond Virginia 23284 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field